Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Surrey
14 May 2013 17:24


Exclusive vacancies may not be shown here, please contact Richard on +44 1494 818057 or richard@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Richard Swann
Account Manager
richard@zenopa.com
+44 1494 818057

Testimonials
I was interviewed and contacted promptly with regular job roles, not only was I contacted but the follow through I had been missing from other agencies was there from the beginning of the process.
Danielle, 2011

Alliance Boots and Walgreens form global partnership

19 June 2012 15:24 in Consumer Healthcare News


Alliance Boots has formed a new strategic partnership with Walgreens, the largest drug store chain in the US, in order to create a global pharmacy-led health and wellbeing enterprise.

The agreement will see Walgreens purchase a 45 percent stake in Alliance Boots for $6.7 billion (4.27 billion pounds), with an option to completely acquire the firm in approximately three years' time.

Bringing these two organisations together will create the world's largest pharmacy-led health and wellbeing retailer, with more than 11,000 stores in 12 countries, a diverse portfolio and unparalleled procurement capabilities.

The deal is also expected to greatly aid the companies' efforts to expand into new territories, while delivering substantial value for shareholders in the long term.

Stefano Pessina, executive chairman of Alliance Boots, said: "I strongly believe that this transaction offers further significant growth opportunities and marks a very positive milestone for the healthcare industry as a whole."

Alliance Boots generated 23 billion pounds in revenue during the 12 months ending on March 31st 2012, representing year-on-year growth of 18.4 percent.ADNFCR-8000103-ID-801388147-ADNFCR

Other news stories from 19/06/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd